Circular RNA PVT1 enhances cell proliferation but inhibits apoptosis through sponging microRNA‐149 in epithelial ovarian cancer

Aim This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ‐PVT1 in EOC. Methods Circ‐PVT1 expression in EOC cell lines and nonmalignant cont...

Full description

Saved in:
Bibliographic Details
Published inThe journal of obstetrics and gynaecology research Vol. 46; no. 4; pp. 625 - 635
Main Authors Sun, Xiaofeng, Luo, Ling, Gao, Yuqiang
Format Journal Article
LanguageEnglish
Published Kyoto, Japan John Wiley & Sons Australia, Ltd 01.04.2020
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aim This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ‐PVT1 in EOC. Methods Circ‐PVT1 expression in EOC cell lines and nonmalignant control cells was detected. Cell proliferation, apoptosis and candidate target miRNA (miR‐149, miR‐183 and miR‐194) expressions were detected in circ‐PVT1 overexpression treated CAOV3 cells and circ‐PVT1 knock‐down treated SKOV3 cells. Furthermore, miR‐149 overexpression and miR‐149 knock‐down plasmids were transfected into circ‐PVT1 dysregulated CAOV3 cells and SKOV3 cells, respectively, and cell proliferation as well as apoptosis were detected. Results Circ‐PVT1 expression was increased in human EOC cell lines (CAOV3, SKOV3, SNU119 and OVCAR3) compared to human normal ovary surface epithelial cell line (HOSEpiC). In SKOV3 cells, cell proliferation was reduced at 48 and 72 h but cell apoptosis rate was increased at 48 h by circ‐PVT1 knock‐down. In CAOV3 cells, cell proliferation was increased at 48 and 72 h but cell apoptosis rate was decreased at 48 h by circ‐PVT1 overexpression. Besides, circ‐PVT1 negatively regulated miR‐149 but not miR‐183 or miR‐194 in SKOV3 and CAOV3 cells. Rescue experiments showed that miR‐149 knock‐down increased cell proliferation but decreased apoptosis in circ‐PVT1 knock‐down treated SKOV3 cells, while miR‐149 overexpression reduced cell proliferation but enhanced apoptosis in circ‐PVT1 overexpression treated CAOV3 cells. Conclusion Circ‐PVT1 enhances cell proliferation but inhibits cell apoptosis through sponging miR‐149 in EOC cells, which suggests that circ‐PVT1 may serve as a treatment target in EOC.
AbstractList Aim This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ‐PVT1 in EOC. Methods Circ‐PVT1 expression in EOC cell lines and nonmalignant control cells was detected. Cell proliferation, apoptosis and candidate target miRNA (miR‐149, miR‐183 and miR‐194) expressions were detected in circ‐PVT1 overexpression treated CAOV3 cells and circ‐PVT1 knock‐down treated SKOV3 cells. Furthermore, miR‐149 overexpression and miR‐149 knock‐down plasmids were transfected into circ‐PVT1 dysregulated CAOV3 cells and SKOV3 cells, respectively, and cell proliferation as well as apoptosis were detected. Results Circ‐PVT1 expression was increased in human EOC cell lines (CAOV3, SKOV3, SNU119 and OVCAR3) compared to human normal ovary surface epithelial cell line (HOSEpiC). In SKOV3 cells, cell proliferation was reduced at 48 and 72 h but cell apoptosis rate was increased at 48 h by circ‐PVT1 knock‐down. In CAOV3 cells, cell proliferation was increased at 48 and 72 h but cell apoptosis rate was decreased at 48 h by circ‐PVT1 overexpression. Besides, circ‐PVT1 negatively regulated miR‐149 but not miR‐183 or miR‐194 in SKOV3 and CAOV3 cells. Rescue experiments showed that miR‐149 knock‐down increased cell proliferation but decreased apoptosis in circ‐PVT1 knock‐down treated SKOV3 cells, while miR‐149 overexpression reduced cell proliferation but enhanced apoptosis in circ‐PVT1 overexpression treated CAOV3 cells. Conclusion Circ‐PVT1 enhances cell proliferation but inhibits cell apoptosis through sponging miR‐149 in EOC cells, which suggests that circ‐PVT1 may serve as a treatment target in EOC.
This study aimed to investigate the influence of circular RNA PVT1 (circ-PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ-PVT1 in EOC. Circ-PVT1 expression in EOC cell lines and nonmalignant control cells was detected. Cell proliferation, apoptosis and candidate target miRNA (miR-149, miR-183 and miR-194) expressions were detected in circ-PVT1 overexpression treated CAOV3 cells and circ-PVT1 knock-down treated SKOV3 cells. Furthermore, miR-149 overexpression and miR-149 knock-down plasmids were transfected into circ-PVT1 dysregulated CAOV3 cells and SKOV3 cells, respectively, and cell proliferation as well as apoptosis were detected. Circ-PVT1 expression was increased in human EOC cell lines (CAOV3, SKOV3, SNU119 and OVCAR3) compared to human normal ovary surface epithelial cell line (HOSEpiC). In SKOV3 cells, cell proliferation was reduced at 48 and 72 h but cell apoptosis rate was increased at 48 h by circ-PVT1 knock-down. In CAOV3 cells, cell proliferation was increased at 48 and 72 h but cell apoptosis rate was decreased at 48 h by circ-PVT1 overexpression. Besides, circ-PVT1 negatively regulated miR-149 but not miR-183 or miR-194 in SKOV3 and CAOV3 cells. Rescue experiments showed that miR-149 knock-down increased cell proliferation but decreased apoptosis in circ-PVT1 knock-down treated SKOV3 cells, while miR-149 overexpression reduced cell proliferation but enhanced apoptosis in circ-PVT1 overexpression treated CAOV3 cells. Circ-PVT1 enhances cell proliferation but inhibits cell apoptosis through sponging miR-149 in EOC cells, which suggests that circ-PVT1 may serve as a treatment target in EOC.
Abstract Aim This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ‐PVT1 in EOC. Methods Circ‐PVT1 expression in EOC cell lines and nonmalignant control cells was detected. Cell proliferation, apoptosis and candidate target miRNA (miR‐149, miR‐183 and miR‐194) expressions were detected in circ‐PVT1 overexpression treated CAOV3 cells and circ‐PVT1 knock‐down treated SKOV3 cells. Furthermore, miR‐149 overexpression and miR‐149 knock‐down plasmids were transfected into circ‐PVT1 dysregulated CAOV3 cells and SKOV3 cells, respectively, and cell proliferation as well as apoptosis were detected. Results Circ‐PVT1 expression was increased in human EOC cell lines (CAOV3, SKOV3, SNU119 and OVCAR3) compared to human normal ovary surface epithelial cell line (HOSEpiC). In SKOV3 cells, cell proliferation was reduced at 48 and 72 h but cell apoptosis rate was increased at 48 h by circ‐PVT1 knock‐down. In CAOV3 cells, cell proliferation was increased at 48 and 72 h but cell apoptosis rate was decreased at 48 h by circ‐PVT1 overexpression. Besides, circ‐PVT1 negatively regulated miR‐149 but not miR‐183 or miR‐194 in SKOV3 and CAOV3 cells. Rescue experiments showed that miR‐149 knock‐down increased cell proliferation but decreased apoptosis in circ‐PVT1 knock‐down treated SKOV3 cells, while miR‐149 overexpression reduced cell proliferation but enhanced apoptosis in circ‐PVT1 overexpression treated CAOV3 cells. Conclusion Circ‐PVT1 enhances cell proliferation but inhibits cell apoptosis through sponging miR‐149 in EOC cells, which suggests that circ‐PVT1 may serve as a treatment target in EOC.
AIMThis study aimed to investigate the influence of circular RNA PVT1 (circ-PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more importantly, to identify the target microRNAs (miRNA) of circ-PVT1 in EOC. METHODSCirc-PVT1 expression in EOC cell lines and nonmalignant control cells was detected. Cell proliferation, apoptosis and candidate target miRNA (miR-149, miR-183 and miR-194) expressions were detected in circ-PVT1 overexpression treated CAOV3 cells and circ-PVT1 knock-down treated SKOV3 cells. Furthermore, miR-149 overexpression and miR-149 knock-down plasmids were transfected into circ-PVT1 dysregulated CAOV3 cells and SKOV3 cells, respectively, and cell proliferation as well as apoptosis were detected. RESULTSCirc-PVT1 expression was increased in human EOC cell lines (CAOV3, SKOV3, SNU119 and OVCAR3) compared to human normal ovary surface epithelial cell line (HOSEpiC). In SKOV3 cells, cell proliferation was reduced at 48 and 72 h but cell apoptosis rate was increased at 48 h by circ-PVT1 knock-down. In CAOV3 cells, cell proliferation was increased at 48 and 72 h but cell apoptosis rate was decreased at 48 h by circ-PVT1 overexpression. Besides, circ-PVT1 negatively regulated miR-149 but not miR-183 or miR-194 in SKOV3 and CAOV3 cells. Rescue experiments showed that miR-149 knock-down increased cell proliferation but decreased apoptosis in circ-PVT1 knock-down treated SKOV3 cells, while miR-149 overexpression reduced cell proliferation but enhanced apoptosis in circ-PVT1 overexpression treated CAOV3 cells. CONCLUSIONCirc-PVT1 enhances cell proliferation but inhibits cell apoptosis through sponging miR-149 in EOC cells, which suggests that circ-PVT1 may serve as a treatment target in EOC.
Author Gao, Yuqiang
Sun, Xiaofeng
Luo, Ling
Author_xml – sequence: 1
  givenname: Xiaofeng
  surname: Sun
  fullname: Sun, Xiaofeng
  organization: Medical School of Hunan University of Chinese Medicine
– sequence: 2
  givenname: Ling
  surname: Luo
  fullname: Luo, Ling
  organization: The Third Xiangya Hospital of Central South University
– sequence: 3
  givenname: Yuqiang
  orcidid: 0000-0001-9092-9865
  surname: Gao
  fullname: Gao, Yuqiang
  email: gualiao4239609@163.com
  organization: Zaozhuang Municipal Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32048451$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1uFSEYhompsT-68AYMiRu7mPaDgQMsm5NaNY01prqdMAzMcDIHRpjRdFfvwGv0SuR4qgsT2cDi-R6-N-8xOggxWISeEzgj5ZxvYn9GGFHwCB0RxkQFgq8OyrtmpJIgVofoOOcNABGKyCfosKbAJOPkCH1f-2SWUSf88f0F_vD5lmAbBh2MzdjYccRTiqN3NunZx4DbZcY-DL71c8Z6itMcs894HlJc-gHnKYbehx5vvUmxGH_e_yBMlRFsJz8PdvR6xPGrTl4HbHbfpKfosdNjts8e7hP06fXl7fpNdX1z9XZ9cV0ZxmqoOm6doK3lWilhmFPcSVVTY6w0rXNOG2M6qYEqWndqJbjsiIMOgGoqDUB9gl7tvSXRl8Xmudn6vIuog41LbmjNGeEgxA59-Q-6iUsKZbtCSQ5c1StaqNM9VaLmnKxrpuS3Ot01BJpdL2Wqb373UtgXD8al3druL_mniAKc74FvfrR3_zc1726u9spfVyaasg
CitedBy_id crossref_primary_10_1007_s00432_022_04328_z
crossref_primary_10_3389_fcell_2022_1044897
crossref_primary_10_3390_cancers12061472
crossref_primary_10_1186_s12935_022_02602_1
crossref_primary_10_3390_cancers14225711
crossref_primary_10_1038_s41420_021_00577_y
crossref_primary_10_1007_s13258_020_01023_6
crossref_primary_10_1080_15476286_2020_1789819
crossref_primary_10_1007_s10620_021_06894_7
crossref_primary_10_1186_s12943_022_01514_y
crossref_primary_10_1186_s13048_021_00891_0
crossref_primary_10_1038_s41420_022_01192_1
crossref_primary_10_1016_j_gendis_2022_05_037
crossref_primary_10_1186_s13046_021_01964_0
crossref_primary_10_1007_s10528_024_10665_0
crossref_primary_10_15252_embj_2022112408
crossref_primary_10_3892_mmr_2021_12323
crossref_primary_10_1186_s11658_021_00284_7
crossref_primary_10_3389_fonc_2021_762960
crossref_primary_10_1007_s00432_022_04468_2
crossref_primary_10_1016_j_reprotox_2023_108499
crossref_primary_10_1016_j_toxlet_2023_07_008
crossref_primary_10_1016_j_ygeno_2020_06_051
crossref_primary_10_1007_s11010_020_03840_5
crossref_primary_10_1186_s11658_022_00385_x
crossref_primary_10_1002_jcla_24009
crossref_primary_10_1016_j_gene_2021_145497
Cites_doi 10.1186/s13059-017-1368-y
10.1016/j.canlet.2016.12.006
10.1016/j.canlet.2011.01.026
10.1016/j.bbrc.2019.03.121
10.7150/jca.31615
10.1007/s00261-019-02175-0
10.1186/s13046-019-1103-5
10.1016/j.clinthera.2018.01.012
10.2217/epi-2017-0142
10.1016/j.biopha.2018.12.007
10.1089/cbr.2018.2641
10.1016/j.biopha.2019.108832
10.7150/ijbs.24360
10.1016/j.biopha.2018.06.112
10.1038/cr.2015.82
10.3233/CBM-190064
10.1016/j.canlet.2015.06.003
10.1016/S0140-6736(18)32552-2
10.1002/ijc.29210
ContentType Journal Article
Copyright 2020 Japan Society of Obstetrics and Gynecology
2020 Japan Society of Obstetrics and Gynecology.
Copyright_xml – notice: 2020 Japan Society of Obstetrics and Gynecology
– notice: 2020 Japan Society of Obstetrics and Gynecology.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TO
H94
K9.
7X8
DOI 10.1111/jog.14190
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE
CrossRef
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1447-0756
EndPage 635
ExternalDocumentID 10_1111_jog_14190
32048451
JOG14190
Genre article
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of Hunan
  funderid: 2018JJ2290
– fundername: National Natural Science Foundation of China
  funderid: 81774362; 81303004
– fundername: National Natural Science Foundation of China
  grantid: 81774362
– fundername: National Natural Science Foundation of Hunan
  grantid: 2018JJ2290
– fundername: National Natural Science Foundation of China
  grantid: 81303004
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OB
1OC
29L
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TO
H94
K9.
7X8
ID FETCH-LOGICAL-c4430-d5ef72be5a997c4f95f8932cce8cbfffacccd8a02923d96758d1f0d002a28c003
IEDL.DBID DR2
ISSN 1341-8076
IngestDate Fri Aug 16 22:18:38 EDT 2024
Thu Oct 10 19:55:41 EDT 2024
Fri Aug 23 01:13:59 EDT 2024
Sat Sep 28 08:25:37 EDT 2024
Sat Aug 24 01:08:52 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords cell apoptosis
circular RNA-PVT1
epithelial ovarian cancer
cell proliferation
microRNA-149
Language English
License 2020 Japan Society of Obstetrics and Gynecology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4430-d5ef72be5a997c4f95f8932cce8cbfffacccd8a02923d96758d1f0d002a28c003
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-9092-9865
PMID 32048451
PQID 2385059362
PQPubID 2045132
PageCount 11
ParticipantIDs proquest_miscellaneous_2354150770
proquest_journals_2385059362
crossref_primary_10_1111_jog_14190
pubmed_primary_32048451
wiley_primary_10_1111_jog_14190_JOG14190
PublicationCentury 2000
PublicationDate April 2020
PublicationDateYYYYMMDD 2020-04-01
PublicationDate_xml – month: 04
  year: 2020
  text: April 2020
PublicationDecade 2020
PublicationPlace Kyoto, Japan
PublicationPlace_xml – name: Kyoto, Japan
– name: Australia
– name: Hoboken
PublicationTitle The journal of obstetrics and gynaecology research
PublicationTitleAlternate J Obstet Gynaecol Res
PublicationYear 2020
Publisher John Wiley & Sons Australia, Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons Australia, Ltd
– name: Wiley Subscription Services, Inc
References 2011; 303
2016; 6
2015; 25
2018; 106
2015; 136
2019; 10
2015; 365
2019; 34
2019; 23
2019; 26
2019
2019; 512
2019; 38
2019; 114
2018; 40
2017; 18
2019; 393
2017; 388
2018; 10
2018; 42
2019; 111
2018; 15
2018; 14
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_23_1
e_1_2_7_11_1
e_1_2_7_22_1
e_1_2_7_10_1
e_1_2_7_21_1
Sun L (e_1_2_7_25_1) 2018; 15
Wang F (e_1_2_7_9_1) 2016; 6
Su Y (e_1_2_7_8_1) 2018; 42
Zhao Y (e_1_2_7_20_1) 2019; 23
Fan B (e_1_2_7_24_1) 2019; 23
References_xml – volume: 14
  start-page: 321
  year: 2018
  end-page: 330
  article-title: Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1
  publication-title: Int J Biol Sci
– volume: 111
  start-page: 244
  year: 2019
  end-page: 250
  article-title: Circular RNA PVT1 acts as a competing endogenous RNA for miR‐497 in promoting non‐small cell lung cancer progression
  publication-title: Biomed Pharmacother
– volume: 10
  start-page: 723
  year: 2018
  end-page: 732
  article-title: Circular RNA PVT1 expression and its roles in acute lymphoblastic leukemia
  publication-title: Epigenomics
– volume: 23
  start-page: 1934
  year: 2019
  end-page: 1946
  article-title: MiR‐15a‐3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 26
  start-page: 151
  year: 2019
  end-page: 161
  article-title: Circular RNA ABCB10 correlates with advanced clinicopathological features and unfavorable survival, and promotes cell proliferation while reduces cell apoptosis in epithelial ovarian cancer
  publication-title: Cancer Biomark
– volume: 18
  start-page: 237
  year: 2017
  article-title: The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription‐competent complex
  publication-title: Genome Biol
– volume: 15
  start-page: 7328
  year: 2018
  end-page: 7334
  article-title: MicroRNA‐149 suppresses the proliferation and increases the sensitivity of ovarian cancer cells to cisplatin by targeting X‐linked inhibitor of apoptosis
  publication-title: Oncol Lett
– volume: 512
  start-page: 716
  year: 2019
  end-page: 722
  article-title: Circular RNA PVT1 promotes metastasis via miR‐145 sponging in CRC
  publication-title: Biochem Biophys Res Commun
– year: 2019
  article-title: Overview of imaging findings associated with systemic therapies in advanced epithelial ovarian cancer
  publication-title: Abdom Radiol (NY)
– volume: 40
  start-page: 361
  year: 2018
  end-page: 371
  article-title: Use of targeted therapeutics in epithelial ovarian cancer: A review of current literature and future directions
  publication-title: Clin Ther
– volume: 6
  start-page: 1167
  year: 2016
  end-page: 1176
  article-title: Circular RNAs as potential biomarkers for cancer diagnosis and therapy
  publication-title: Am J Cancer Res
– volume: 10
  start-page: 3908
  year: 2019
  end-page: 3913
  article-title: circGFRA1 promotes ovarian cancer progression by sponging miR‐449a
  publication-title: J Cancer
– volume: 303
  start-page: 73
  year: 2011
  end-page: 83
  article-title: Chemotherapy in epithelial ovarian cancer
  publication-title: Cancer Lett
– volume: 106
  start-page: 61
  year: 2018
  end-page: 67
  article-title: Long non‐coding RNA PVT1 promotes cell proliferation and invasion through regulating miR‐133a in ovarian cancer
  publication-title: Biomed Pharmacother
– volume: 34
  start-page: 110
  year: 2019
  end-page: 118
  article-title: Upregulation of circular RNA VPS13C‐has‐circ‐001567 promotes ovarian cancer cell proliferation and invasion
  publication-title: Cancer Biother Radiopharm
– volume: 136
  start-page: E359
  year: 2015
  end-page: E386
  article-title: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
  publication-title: Int J Cancer
– volume: 25
  start-page: 981
  year: 2015
  end-page: 984
  article-title: Circular RNA is enriched and stable in exosomes: A promising biomarker for cancer diagnosis
  publication-title: Cell Res
– volume: 388
  start-page: 208
  year: 2017
  end-page: 219
  article-title: Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer
  publication-title: Cancer Lett
– volume: 393
  start-page: 1240
  year: 2019
  end-page: 1253
  article-title: Epithelial ovarian cancer
  publication-title: Lancet
– volume: 42
  start-page: 1786
  year: 2018
  end-page: 1798
  article-title: Circular RNA, a novel marker for cancer determination (review)
  publication-title: Int J Mol Med
– volume: 38
  start-page: 110
  year: 2019
  article-title: HOXD‐AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR‐186‐5p and PIK3R3
  publication-title: J Exp Clin Cancer Res
– volume: 23
  start-page: 5603
  year: 2019
  end-page: 5610
  article-title: Circular RNA circ‐SMAD7 promoted ovarian cancer cell proliferation and metastasis by suppressing KLF6
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 365
  start-page: 141
  year: 2015
  end-page: 148
  article-title: Circular RNA: A new star of noncoding RNAs
  publication-title: Cancer Lett
– volume: 114
  year: 2019
  article-title: Circ‐CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR‐1236‐3p sponge
  publication-title: Biomed Pharmacother
– ident: e_1_2_7_14_1
  doi: 10.1186/s13059-017-1368-y
– ident: e_1_2_7_10_1
  doi: 10.1016/j.canlet.2016.12.006
– ident: e_1_2_7_6_1
  doi: 10.1016/j.canlet.2011.01.026
– ident: e_1_2_7_12_1
  doi: 10.1016/j.bbrc.2019.03.121
– ident: e_1_2_7_22_1
  doi: 10.7150/jca.31615
– ident: e_1_2_7_3_1
  doi: 10.1007/s00261-019-02175-0
– ident: e_1_2_7_23_1
  doi: 10.1186/s13046-019-1103-5
– volume: 23
  start-page: 1934
  year: 2019
  ident: e_1_2_7_24_1
  article-title: MiR‐15a‐3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1
  publication-title: Eur Rev Med Pharmacol Sci
  contributor:
    fullname: Fan B
– volume: 42
  start-page: 1786
  year: 2018
  ident: e_1_2_7_8_1
  article-title: Circular RNA, a novel marker for cancer determination (review)
  publication-title: Int J Mol Med
  contributor:
    fullname: Su Y
– volume: 15
  start-page: 7328
  year: 2018
  ident: e_1_2_7_25_1
  article-title: MicroRNA‐149 suppresses the proliferation and increases the sensitivity of ovarian cancer cells to cisplatin by targeting X‐linked inhibitor of apoptosis
  publication-title: Oncol Lett
  contributor:
    fullname: Sun L
– ident: e_1_2_7_5_1
  doi: 10.1016/j.clinthera.2018.01.012
– volume: 6
  start-page: 1167
  year: 2016
  ident: e_1_2_7_9_1
  article-title: Circular RNAs as potential biomarkers for cancer diagnosis and therapy
  publication-title: Am J Cancer Res
  contributor:
    fullname: Wang F
– ident: e_1_2_7_11_1
  doi: 10.2217/epi-2017-0142
– ident: e_1_2_7_13_1
  doi: 10.1016/j.biopha.2018.12.007
– ident: e_1_2_7_18_1
  doi: 10.1089/cbr.2018.2641
– ident: e_1_2_7_19_1
  doi: 10.1016/j.biopha.2019.108832
– ident: e_1_2_7_15_1
  doi: 10.7150/ijbs.24360
– ident: e_1_2_7_16_1
  doi: 10.1016/j.biopha.2018.06.112
– ident: e_1_2_7_17_1
  doi: 10.1038/cr.2015.82
– ident: e_1_2_7_21_1
  doi: 10.3233/CBM-190064
– volume: 23
  start-page: 5603
  year: 2019
  ident: e_1_2_7_20_1
  article-title: Circular RNA circ‐SMAD7 promoted ovarian cancer cell proliferation and metastasis by suppressing KLF6
  publication-title: Eur Rev Med Pharmacol Sci
  contributor:
    fullname: Zhao Y
– ident: e_1_2_7_7_1
  doi: 10.1016/j.canlet.2015.06.003
– ident: e_1_2_7_2_1
  doi: 10.1016/S0140-6736(18)32552-2
– ident: e_1_2_7_4_1
  doi: 10.1002/ijc.29210
SSID ssj0017918
Score 2.4131641
Snippet Aim This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more...
This study aimed to investigate the influence of circular RNA PVT1 (circ-PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more...
Abstract Aim This study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and...
AimThis study aimed to investigate the influence of circular RNA PVT1 (circ‐PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more...
AIMThis study aimed to investigate the influence of circular RNA PVT1 (circ-PVT1) on epithelial ovarian cancer (EOC) cell proliferation and apoptosis, more...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 625
SubjectTerms Apoptosis
Apoptosis - genetics
Carcinoma, Ovarian Epithelial - genetics
cell apoptosis
Cell growth
Cell Line, Tumor
Cell proliferation
Cell Proliferation - genetics
Cell surface
Circular RNA
circular RNA‐PVT1
Epithelial cells
epithelial ovarian cancer
Female
Humans
MicroRNAs
MicroRNAs - genetics
microRNA‐149
miRNA
Ovarian cancer
Ovarian Neoplasms - genetics
Plasmids
RNA, Circular - genetics
RNA, Long Noncoding - genetics
Title Circular RNA PVT1 enhances cell proliferation but inhibits apoptosis through sponging microRNA‐149 in epithelial ovarian cancer
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjog.14190
https://www.ncbi.nlm.nih.gov/pubmed/32048451
https://www.proquest.com/docview/2385059362
https://search.proquest.com/docview/2354150770
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9VAFD4hLAwbX_i4imYwLtyU3E6nr7giKBIS0BAwLEyaeUKDts1trwtX-g_4jfwSz5k-IhAT465JOzNt55wz32m_-Q7Aa7ST1PBIBEakeSAy4QIVuzzIJc9TnmWhVp5tcZjsnYj90_h0Bd6Oe2F6fYjpgxt5ho_X5OBStX86eX2Gbo7rGcbfMEqJzvXuaJKOItVNvw0OozQJ7iaDqpBn8Ywtr69FtwDmdbzqF5zde_BlvNWeZ3KxtezUlv5xQ8XxP5_lPtwdgCjb7i3nAazY6iHcORh-ta_Dr51y4Tmq7Ohwm336fBwyW52TjbSMvvazhur9ONtbEFPLjpXVeanKrmWyqZuubsuWDWWAGBFxqRwS-0YEQOzx6uclZk3YhNmGtoV8RT9g9XfM3GXFNA2zeAQnu--Pd_aCoV5DoIWI5oGJrUu5srHM81QLl8cO0RDX2mZaOeek1tpkcs4RVJqcMhUTurnBmCx5pjG8PIbVqq7sU2DKJXZuMpdGIhLCJgoDujXcogFpJxI1g1fjzBVNL8tRTOlMfVb4lzmDjXFOi8Ez2wIhSuzLGPIZbE6n0afo1cnK1ku6JhYElFPs4klvC9MoESkdizicwRs_o38fvtj_-MEfPPv3S5_DGqeE3lODNmC1WyztC0Q9nXrpzfs3Y9_-eQ
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtRAEC2FIEEu7CQDARrEgYujmXZ7k7hEgTCEZEDRBOWCLPeWWAHbGntyyAn-gG_kS6hqLyIgJMTNkpe2u-tVv2pXvwJ4jnYSae4LT4so8UQsrCcDm3hJxpOIx_FESZdtMQunR2LvODhegZf9XphWH2JYcCNkOH9NAKcF6V9RXp4gznFCuwJXEe4-FW54dTiIR5HuptsIh36aJHfDTlfI5fH0t16ejf6gmJcZq5tydm_Cp_5l20yTs61lI7fUxW86jv_7NbfgRsdF2XZrPLdhxRR34NpB97f9LnzbyRcuTZUdzrbZh4_zCTPFKZlJzWjBn1VU8sea1oiYXDYsL05zmTc1y6qyaso6r1lXCYhRLi5VRGJfKAcQn_jj63cMnPAWZiraGfIZocDKcwzes4IpamZxD452X893pl5XssFTQvhjTwfGRlyaIEuSSAmbBBYJEVfKxEpaazOllI6zMUdeqRMKVvTEjjW65YzHCj3MfVgtysJsAJM2NGMd28gXvhAmlOjTjeYGbUhZEcoRPOuHLq1aZY50iGjKk9R15gg2-0FNO3DWKbKUwFUy5CN4OpxGWFHXZYUpl3RNIIgrR_iI9dYYhlZ8EjsWwWQEL9yQ_r35dO_9G3fw4N8vfQLXp_OD_XT_7ezdQ1jjFN-7TKFNWG0WS_MISVAjHztb_wkzVQKg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVcKM-ytIBBHLik2nWcl3qqWpZSYKmqFvWAFMWvNgKSaJPlwKn8g_7G_pLOOA9REBLiFil-xPbM-Btn_A3AS5STSHNfeFpEiSdiYT0Z2MRLMp5EPI4nSrpoi1m4dyz2T4KTJdjq78K0_BDDgRtphrPXpOCVtr8qeXmKao772Q24KUJEvoSIDgfuKKLddPfg0EwT427Y0Qq5MJ6-6vXN6A-EeR2wuh1nugqf-29tA02-bC4aual-_Ebj-J-DuQO3OyTKtlvRuQtLprgHKx-6f-334edOPndBquxwts0OPh1NmCnOSEhqRsf9rKKEP9a0IsTkomF5cZbLvKlZVpVVU9Z5zbo8QIwicSkfEvtGEYDY4uX5BbpNWIWZiu6FfEVFYOV3dN2zginqZv4Ajqevj3b2vC5hg6eE8MeeDoyNuDRBliSREjYJLMIhrpSJlbTWZkopHWdjjqhSJ-Sq6IkdazTKGY8V2peHsFyUhXkETNrQjHVsI1_4QphQokU3mhuUIGVFKEfwol-5tGp5OdLBnylPUzeZI9jo1zTtVLNOEaMELo8hH8Hz4TUqFU1dVphyQWUCQUg5wibWWlkYevGJ6lgEkxG8civ69-7T_Y9v3MPjfy_6DFYOdqfp-7ezd-twi5Nz78KENmC5mS_ME0RAjXzqJP0KMz0BTw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Circular+RNA+PVT1+enhances+cell+proliferation+but+inhibits+apoptosis+through+sponging+microRNA-149+in+epithelial+ovarian+cancer&rft.jtitle=The+journal+of+obstetrics+and+gynaecology+research&rft.au=Sun%2C+Xiaofeng&rft.au=Luo%2C+Ling&rft.au=Gao%2C+Yuqiang&rft.date=2020-04-01&rft.eissn=1447-0756&rft.volume=46&rft.issue=4&rft.spage=625&rft.epage=635&rft_id=info:doi/10.1111%2Fjog.14190&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-8076&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-8076&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-8076&client=summon